CSI Market
Sign In | Register

Lakewood-Amedex Biotherapeutics (LABT) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access LABT Annual Balance Sheets →
This balance sheet overview for Lakewood-Amedex Biotherapeutics spans from to Jun 30 2026, showing how the company's assets, liabilities, and equity have evolved across reporting periods.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025)
Assets
Cash & cash equivalent2.58
Marketable Securities2.00
Cash & Short-term Investments4.00
Notes Receivable, Current0.00
Total loans net0.26
Total Current Assets4.85
Equipment/Property/Plant Net0.01
Other Assets, Noncurrent0.11
Total Assets4.96
Liabilities
Accounts Payable0.17
Other Liabilities, Current0.46
Total Current Liabilities0.63
Total Long-term Debt0.00
Other liabilities, Noncurrent0.00
Total Liabilities0.63
Stockholders' Equity
Common Stock Value0.00
Treasury Stock Value-0.15
Additional Paid In Capital Common Stock73.12
Retained Earnings / Accumulated Deficit-68.64
Common Stockholder's Equity4.33
Total Stockholder's Equity4.33
Liabilities & Stockholder's Equity4.96
4 historic quarters locked

Sign in to unlock the full Lakewood-Amedex Biotherapeutics balance sheet history.

Sign In Create Free Account

About Lakewood Amedex Biotherapeutics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001213900-26-089380

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License